[go: up one dir, main page]

BR0011478A - Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal - Google Patents

Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal

Info

Publication number
BR0011478A
BR0011478A BR0011478-2A BR0011478A BR0011478A BR 0011478 A BR0011478 A BR 0011478A BR 0011478 A BR0011478 A BR 0011478A BR 0011478 A BR0011478 A BR 0011478A
Authority
BR
Brazil
Prior art keywords
methods
intranasal administration
composition
immunizing
inducing
Prior art date
Application number
BR0011478-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert C Huebner
Jacquelyn S Sampson
George M Carlone
Edwin Ades
David E Briles
Original Assignee
Uab Research Foundation
Aventis Pasteur
Ct S For Disease Control And P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation, Aventis Pasteur, Ct S For Disease Control And P filed Critical Uab Research Foundation
Publication of BR0011478A publication Critical patent/BR0011478A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR0011478-2A 1999-06-10 2000-06-09 Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal BR0011478A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13842299P 1999-06-10 1999-06-10
US58783300A 2000-06-06 2000-06-06
PCT/US2000/040176 WO2000076541A1 (fr) 1999-06-10 2000-06-09 Vaccin a combinaison de proteines de surface pneumococciques

Publications (1)

Publication Number Publication Date
BR0011478A true BR0011478A (pt) 2002-03-19

Family

ID=26836182

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011478-2A BR0011478A (pt) 1999-06-10 2000-06-09 Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal

Country Status (7)

Country Link
EP (1) EP1189632A4 (fr)
JP (1) JP2003519089A (fr)
AU (1) AU6121000A (fr)
BR (1) BR0011478A (fr)
CA (1) CA2379327A1 (fr)
MX (1) MXPA01012721A (fr)
WO (1) WO2000076541A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US20010016200A1 (en) 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP1477802A1 (fr) * 2003-05-16 2004-11-17 Erasmus Universiteit Rotterdam Procédé de selection et de fabrication des constituents du vaccine, et leur utilisation en vaccines
JP2010501012A (ja) * 2006-08-17 2010-01-14 ザ ユーエービー リサーチ ファウンデーション 免疫原性PcpAポリペプチドおよびその使用
RU2510281C2 (ru) * 2012-06-22 2014-03-27 Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
KR101627285B1 (ko) * 2014-06-05 2016-06-07 한국생명공학연구원 PspA를 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
AU5958594A (en) * 1992-12-24 1994-07-19 Med Immune, Inc. Method of protection against (streptococcus pneumoniae) with transformed mycobacteria
AU758764B2 (en) * 1998-03-02 2003-03-27 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Epitope peptides immunogenic against (streptococcus pneumoniae)
JP2002516251A (ja) * 1998-04-23 2002-06-04 ユーエイビー リサーチ ファンデーション 肺炎球菌表面プロテインC(PspC)のエピトープ領域およびその菌株選択、ならびにそのための使用法

Also Published As

Publication number Publication date
AU6121000A (en) 2001-01-02
EP1189632A1 (fr) 2002-03-27
MXPA01012721A (es) 2004-10-14
JP2003519089A (ja) 2003-06-17
WO2000076541A1 (fr) 2000-12-21
EP1189632A4 (fr) 2002-08-21
CA2379327A1 (fr) 2000-12-21

Similar Documents

Publication Publication Date Title
BRPI0010612B8 (pt) vacinas
BR0113822A (pt) Vacina
BR0009166A (pt) Vacina
NZ507717A (en) Derivatives of pneumococcal choline binding proteins for vaccines
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
ZA88798B (en) Dental anti-plaque and anti-caries agent
BR0010682A (pt) Novas composições
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
MX2008013993A (es) Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
EP0835133A4 (fr) Compositions recombinantes et compositions combinees de virus de la rage et de la variole, et leurs utilisations
HK1043943A1 (zh) 肺炎链球菌蛋白质和疫苗
AU9094191A (en) Recombinant avirulent salmonella antifertility vaccines
EP2275122A3 (fr) Vaccins contre le streptococcus pneumoniae à base de protéine
EP0090581A3 (fr) Petits peptides specifiques des antigènes de la fièvre aphteuse
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
BR0011478A (pt) Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
WO2001081380A3 (fr) Proteine pneumococcique immunogenique et ses compositions de vaccins
WO2000058475A3 (fr) Proteines
ZA965586B (en) Coccidiosis poultry vaccine
BG103959A (en) Carbocyclic nucleoside hemisulphate and its application in the treatment of viral infections
AU3172095A (en) Coccidiosis poultry vaccine
AU8467201A (en) Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
WO2001034184A3 (fr) Methodes et compositions de protection contre l'herpesvirus bovin 1
MY127452A (en) Vaccines.
BR0114403A (pt) Polipeptìdeos de "haemophilus influenzae" que podem ser usados para fins de profilaxia, diagnóstico e/ou terapia

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.